Michael French Quoted in 340B Report Article Detailing Recent 340B Contract Pharmacy Developments
Quarles & Brady attorney Michael French, a Chicago-based member of the Health & Life Sciences Practice Group, was quoted in a 340B Report article detailing recent 340B contract pharmacy developments related to ongoing evolving state laws and recent court decisions. As a result, there have been increased restrictions by pharmaceutical manufacturers, pushback and legal battles.
Both the uptick in manufacturer contract pharmacy restrictions and the increased interest in related legislation on the state level were likely driven in part by January’s appellate court decision, said Michael French, a healthcare attorney at Quarles whose clients include drugmakers, pharmacies, and covered entities.
“One of the more significant areas where we’ve seen the impact of the Third Circuit decision is in the growing appetite for states themselves to address manufacturer restrictions,” French said. “The decision has also led to bolder and more aggressive manufacturer restrictions, as well as further erosion of long-standing agency authority over certain parts of the 340B program, among other impacts.”